| NCT03400956 |
Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 4) |
https://ClinicalTrials.gov/show/NCT03400956 |
Active, not recruiting |
Bayer |
2019-03-23 |
| NCT03400943 |
Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 3) |
https://ClinicalTrials.gov/show/NCT03400943 |
Active, not recruiting |
Bayer |
2019-06-09 |
| NCT03400826 |
Effects of Simvastatin on Uterine Leiomyoma Size |
https://ClinicalTrials.gov/show/NCT03400826 |
Recruiting |
Johns Hopkins University |
2024-01-01 |
| NCT03369600 |
Characterisation of Uterine Fibroid Tissue Stiffness |
https://ClinicalTrials.gov/show/NCT03369600 |
Enrolling by invitation |
University of Ottawa |
2020-07-31 |
| NCT04295109 |
Comparison of the Effects of Fentanyl, Oxycodone, Butorphanol on Gastrointestinal Function |
https://ClinicalTrials.gov/show/NCT04295109 |
Recruiting |
The First Affiliated Hospital with Nanjing Medical University |
2020-07-31 |
| NCT03342859 |
Mode of Action Study of Vilaprisan and Ulipristal Acetate in Patients With Uterine Fibroids for Whom Surgery is Planned |
https://ClinicalTrials.gov/show/NCT03342859 |
Active, not recruiting |
Bayer |
2018-12-17 |
| NCT03328260 |
High Intensity Focused Ultrasound in Uterine Myoma |
https://ClinicalTrials.gov/show/NCT03328260 |
Completed |
Seoul National University Hospital |
2018-08-31 |
| NCT03323905 |
Single Arm Study Using the Symphony – MRI Guided Focused Ultrasound System for the Treatment of Leiomyomas |
https://ClinicalTrials.gov/show/NCT03323905 |
Recruiting |
Sunnybrook Health Sciences Centre |
2020-09-30 |
| NCT03317795 |
Treatment of Heavy Menstrual Bleeding in Women With Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT03317795 |
Recruiting |
Mayo Clinic |
2020-06-30 |
| NCT03271489 |
Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women |
https://ClinicalTrials.gov/show/NCT03271489 |
Active, not recruiting |
AbbVie |
2023-08-18 |
| NCT03194646 |
Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT03194646 |
Active, not recruiting |
Bayer |
2019-05-10 |
| NCT03103087 |
LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT03103087 |
Active, not recruiting |
Myovant Sciences GmbH |
2019-07-01 |
| NCT03072446 |
Uterine Fibroid Embolization (UFE) for Symptomatic Fibroids: Comparison of Gel-Bead to Commonly Used Embolic Agents. |
https://ClinicalTrials.gov/show/NCT03072446 |
Completed |
University Hospital Southampton NHS Foundation Trust |
2018-06-30 |
| NCT03070951 |
Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT03070951 |
Active, not recruiting |
ObsEva SA |
2019-09-16 |
| NCT03070899 |
Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT03070899 |
Active, not recruiting |
ObsEva SA |
2020-03-31 |
| NCT03049735 |
LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT03049735 |
Active, not recruiting |
Myovant Sciences GmbH |
2019-04-29 |
| NCT03009812 |
Transverse vs Longitudinal Incision in Myomectomy |
https://ClinicalTrials.gov/show/NCT03009812 |
Completed |
Ain Shams University |
2018-01-31 |
| NCT02954744 |
High-intensity Focused Ultrasound in Treatment of Uterine Fibroid |
https://ClinicalTrials.gov/show/NCT02954744 |
Completed |
Queen Mary Hospital, Hong Kong |
2017-08-31 |
| NCT02942537 |
Study of Volume Reduction of Uterine Fibroids After Embolization or Microwave Treatment |
https://ClinicalTrials.gov/show/NCT02942537 |
Recruiting |
Karolinska Institutet |
2019-12-31 |
| NCT02889848 |
Safety and Tolerability of Collagenase Clostridium Histolyticum (EN3835) to Treat Uterine Leiomyoma (Fibroids) |
https://ClinicalTrials.gov/show/NCT02889848 |
Completed |
Advance Biofactures Corporation |
2018-10-05 |
| NCT02829333 |
The Effect of Anesthetic Technique on VEGF-C and PGE2 |
https://ClinicalTrials.gov/show/NCT02829333 |
Completed |
General Hospital of Ningxia Medical University |
2016-04-30 |
| NCT02620345 |
Fibroids in Women of Reproductive Age and Women Pregnancy |
https://ClinicalTrials.gov/show/NCT02620345 |
Completed |
Triệu, Nguyễn Thị, M.D. |
2015-10-31 |
| NCT02563392 |
Does Preventive Uterine Artery Occlusion During Laparoscopic Myomectomy Impact on Ovarian Reserve Markers? |
https://ClinicalTrials.gov/show/NCT02563392 |
Recruiting |
University Hospital, Geneva |
2022-05-31 |
| NCT02654054 |
Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women |
https://ClinicalTrials.gov/show/NCT02654054 |
Completed |
AbbVie |
2018-01-18 |
| NCT02520414 |
Symphion® System In-Office Study |
https://ClinicalTrials.gov/show/NCT02520414 |
Completed |
Boston Scientific Corporation |
2015-03-31 |
| NCT02472184 |
Optimal Order of Concurrent Office Hysteroscopy and Endometrial Biopsy |
https://ClinicalTrials.gov/show/NCT02472184 |
Completed |
University of South Florida |
2017-03-31 |
| NCT02470741 |
Pilot of Letrozole for Uterine Myomas |
https://ClinicalTrials.gov/show/NCT02470741 |
Completed |
University of California, San Francisco |
2017-12-31 |
| NCT02465814 |
Assess Safety and Efficacy of Vilaprisan in Patients With Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT02465814 |
Completed |
Bayer |
2016-10-31 |
| NCT02425878 |
Ulipristal Acetate 10 mg and Asisted Reproduction |
https://ClinicalTrials.gov/show/NCT02425878 |
Completed |
Instituto Valenciano de Infertilidad, IVI VALENCIA |
2016-05-31 |
| NCT02410018 |
Safety and Effectiveness of OCL 503 in the Treatment of Women With Leiomyomata |
https://ClinicalTrials.gov/show/NCT02410018 |
Completed |
IMBiotechnologies Ltd. |
2016-06-30 |
| NCT02392585 |
Single or Triple Uterine Tourniquet at Myomectomy |
https://ClinicalTrials.gov/show/NCT02392585 |
Completed |
Ataturk University |
2016-03-31 |
| NCT02386137 |
Factors Influencing Volumetric MR-HIFU Ablation of Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT02386137 |
Completed |
University Hospital, Bordeaux |
2017-10-31 |
| NCT02323646 |
Safety and Efficacy of Telapristone Acetate (Proellex®) Administered Vaginally for the Treatment of Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT02323646 |
Completed |
Repros Therapeutics Inc. |
2017-04-06 |
| NCT02301897 |
A Multi-Center, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT02301897 |
Completed |
Repros Therapeutics Inc. |
2017-06-02 |
| NCT02228174 |
Sonography Guided Transcervical Ablation of Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT02228174 |
Completed |
Gynesonics |
2017-10-18 |
| NCT02227316 |
Effectiveness of IV Acetaminophen and IV Ibuprofen in Reducing Post Procedural Pain in the UFE Procedure |
https://ClinicalTrials.gov/show/NCT02227316 |
Completed |
University of California, Los Angeles |
2016-09-30 |
| NCT02209545 |
Misoprostol for Reduction of Blood Loss During Fibroid Surgery |
https://ClinicalTrials.gov/show/NCT02209545 |
Recruiting |
Northwestern University |
2020-08-31 |
| NCT02147197 |
A Study of the Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas |
https://ClinicalTrials.gov/show/NCT02147197 |
Completed |
Allergan |
2016-03-29 |
| NCT02147158 |
A Study of the Efficacy and Safety of Ulipristal Acetate Intermittent Treatment for Abnormal Uterine Bleeding Associated With Leiomyomas |
https://ClinicalTrials.gov/show/NCT02147158 |
Completed |
Allergan |
2016-11-24 |
| NCT02086435 |
Intracorporeal Versus Extracorporeal Morcellation: Clinical Efficacy and Safety Outcomes |
https://ClinicalTrials.gov/show/NCT02086435 |
Completed |
University Magna Graecia |
2014-12-31 |
| NCT02059954 |
Vaginal vs. Laparoscopic Hysterectomy |
https://ClinicalTrials.gov/show/NCT02059954 |
Completed |
Medical University of Graz |
2016-08-31 |
| NCT01285960 |
ExAblate UF V2 System for the Treatment of Symptomatic Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT01285960 |
Completed |
InSightec |
2016-04-30 |
| NCT02056717 |
Use of Dexamethasone in Uterine Artery Embolization |
https://ClinicalTrials.gov/show/NCT02056717 |
Completed |
Severance Hospital |
2015-04-30 |
| NCT02049242 |
Uterine Tourniquet at Open Myomectomy |
https://ClinicalTrials.gov/show/NCT02049242 |
Completed |
Ataturk University |
2014-12-31 |
| NCT01984632 |
Barbed Suture in Single-port Laparoscopic Myomectomy |
https://ClinicalTrials.gov/show/NCT01984632 |
Completed |
CHA University |
2014-12-31 |
| NCT01946178 |
Clinical Study of the Mirabilis High-Intensity Focused Ultrasound System for Non-Invasive Treatment of Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT01946178 |
Completed |
Mirabilis Medica, Inc. |
2015-05-31 |
| NCT01937104 |
ONSD According to the Position During Laparoscopy |
https://ClinicalTrials.gov/show/NCT01937104 |
Completed |
Chosun University Hospital |
2014-09-30 |
| NCT01873378 |
GnRH Agonist Pretreatment in Hysteroscopic Myomectomy |
https://ClinicalTrials.gov/show/NCT01873378 |
Completed |
Azienda Ospedaliera S. Maria della Misericordia |
2015-08-31 |
| NCT01861015 |
Vasopressin Versus Epinephrine in Myomectomy |
https://ClinicalTrials.gov/show/NCT01861015 |
Completed |
CHA University |
2014-03-31 |
| NCT01852734 |
Uterine Fibroid Embolization- Long Term Follow up and Technical Perspectives |
https://ClinicalTrials.gov/show/NCT01852734 |
Completed |
Odense University Hospital |
2016-04-30 |
| NCT01840124 |
Uterine Leiomyoma Treatment With Radiofrequency Ablation |
https://ClinicalTrials.gov/show/NCT01840124 |
Completed |
University of California, San Francisco |
2020-01-31 |
| NCT01817530 |
Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF) |
https://ClinicalTrials.gov/show/NCT01817530 |
Completed |
AbbVie |
2015-06-30 |
| NCT01750008 |
Laparoscopic Uterine Sparing Techniques Outcomes and Reinterventions |
https://ClinicalTrials.gov/show/NCT01750008 |
Completed |
Acessa Health, Inc. |
2013-09-30 |
| NCT01745432 |
Assessment of the Manageability and Safety of ADBLOCK Adhesion Barrier System in Laparoscopic Gynaecological Surgery |
https://ClinicalTrials.gov/show/NCT01745432 |
Completed |
Terumo Europe N.V. |
2015-08-31 |
| NCT01739621 |
Safety, Pharmacokinetics and Efficacy of Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Premenopausal Women With Uterine Fibroids Who Have Completed ZPV-200 |
https://ClinicalTrials.gov/show/NCT01739621 |
Completed |
Repros Therapeutics Inc. |
2014-04-30 |
| NCT01715597 |
Study on the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women With Uterine Myoma |
https://ClinicalTrials.gov/show/NCT01715597 |
Completed |
Seoul National University Hospital |
2017-10-31 |
| NCT01631903 |
Extension of Study ZPV-200 |
https://ClinicalTrials.gov/show/NCT01631903 |
Completed |
Repros Therapeutics Inc. |
2014-04-30 |
| NCT01629563 |
PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata |
https://ClinicalTrials.gov/show/NCT01629563 |
Completed |
PregLem SA |
2015-01-31 |
| NCT01588899 |
China Clinical Trial for Therapeutic MR-HIFU Ablation of Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT01588899 |
Completed |
Philips Healthcare |
2014-12-31 |
| NCT01530802 |
Temporary Clipping of the Uterine Arteries During Laparoscopic Myomectomy |
https://ClinicalTrials.gov/show/NCT01530802 |
Completed |
Charite University, Berlin, Germany |
NA |
| NCT01492179 |
Intravenous or Intra-abdominal Local Anesthetics for Postoperative Pain Management. |
https://ClinicalTrials.gov/show/NCT01492179 |
Completed |
Örebro University, Sweden |
2013-06-30 |
| NCT01452659 |
Efficacy and Safety of TAK-385 in the Treatment of Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT01452659 |
Completed |
Takeda |
2012-09-30 |
| NCT01451424 |
Evaluation of Safety, Pharmacokinetics, and Efficacy of Proellex Administered Vaginally in Women With Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT01451424 |
Completed |
Repros Therapeutics Inc. |
2012-12-31 |
| NCT01441635 |
Safety and Efficacy Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT01441635 |
Completed |
AbbVie |
2013-11-30 |
| NCT01379313 |
The Effect of Different I:E Ratio on Gas Exchange of Patients Undergoing Gynecologic Laparoscopic Surgery With Trendelenburg Position |
https://ClinicalTrials.gov/show/NCT01379313 |
Completed |
Samsung Medical Center |
2012-03-31 |
| NCT01377519 |
Magnetic Resonance Guided Focused Ultrasound for Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT01377519 |
Completed |
University of California, San Francisco |
2012-09-30 |
| NCT01369758 |
MyoSure Hysteroscopic Tissue Removal System Registry Study |
https://ClinicalTrials.gov/show/NCT01369758 |
Completed |
Hologic, Inc. |
2013-05-31 |
| NCT01338831 |
Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Breast Cancer |
https://ClinicalTrials.gov/show/NCT01338831 |
Completed |
Novartis |
2014-03-31 |
| NCT04145518 |
Mechanistic Characterization of Uterine Pain |
https://ClinicalTrials.gov/show/NCT04145518 |
Recruiting |
NorthShore University HealthSystem |
2023-08-31 |
| NCT04091529 |
Tailored Radiofrequency Ablation of Uterine Myomas |
https://ClinicalTrials.gov/show/NCT04091529 |
Completed |
International Evangelical Hospital |
2019-03-01 |
| NCT04073485 |
Microwave Ablation for Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT04073485 |
Recruiting |
Chinese University of Hong Kong |
2022-06-30 |
| NCT03985449 |
Implementation of Uterine Fibroid Option Grid Patient Decision Aids Across Five Organizational Settings |
https://ClinicalTrials.gov/show/NCT03985449 |
Recruiting |
Dartmouth-Hitchcock Medical Center |
2021-05-30 |
| NCT03927651 |
ICG to Assess Ovarian Perfusion |
https://ClinicalTrials.gov/show/NCT03927651 |
Recruiting |
Northwestern University |
2020-04-30 |
| NCT03886220 |
A Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women |
https://ClinicalTrials.gov/show/NCT03886220 |
Recruiting |
AbbVie |
2021-09-20 |
| NCT03847077 |
Trial of a Patient Education Tool For Leiomyoma |
https://ClinicalTrials.gov/show/NCT03847077 |
Completed |
Loyola University |
2018-10-31 |
| NCT03751124 |
Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT03751124 |
Active, not recruiting |
Myovant Sciences GmbH |
2021-02-28 |
| NCT03535610 |
Uterine Artery Embolization With Microspheres in Patients With Leiomyoma. |
https://ClinicalTrials.gov/show/NCT03535610 |
Active, not recruiting |
Scitech Produtos Medicos Ltda |
2020-02-20 |
| NCT03500367 |
Efficacy and Safety of Rapamycin (Sirolimus) in the Treatment of Symptomatic Uterine Fibroids and Leiomyomatosis |
https://ClinicalTrials.gov/show/NCT03500367 |
Recruiting |
Peking Union Medical College Hospital |
2022-06-30 |
| NCT03476928 |
A Study to Assess the Safety and Efficacy of Vilaprisan in Japanese Subjects With Uterine Fibroids and Heavy Menstrual Bleeding |
https://ClinicalTrials.gov/show/NCT03476928 |
Active, not recruiting |
Bayer |
2021-02-28 |
| NCT03427671 |
OCL 500 Treatment of Women With Symptomatic Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT03427671 |
Completed |
IMBiotechnologies Ltd. |
2019-09-03 |
| NCT03412890 |
LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT03412890 |
Active, not recruiting |
Myovant Sciences GmbH |
2020-01-24 |
| NCT01152112 |
HOME Study: Hysteroscopic Office Myomectomy Evaluation |
https://ClinicalTrials.gov/show/NCT01152112 |
Completed |
Hologic, Inc. |
2012-01-31 |
| NCT01142791 |
Safety Study of ExAblate for the Treatment of Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT01142791 |
Completed |
InSightec |
2012-04-30 |
| NCT01141062 |
Therapeutic MRI Guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT01141062 |
Completed |
Philips Healthcare |
2011-10-31 |
| NCT01092988 |
A Clinical Study to Evaluate Safety of the ExAblate 2100 UF V2 System in the Treatment of Symptomatic Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT01092988 |
Completed |
InSightec |
2012-02-29 |
| NCT01069094 |
A Study of Progenta (CDB-4124) in Pre-menopausal Women With Symptomatic Leiomyomata |
https://ClinicalTrials.gov/show/NCT01069094 |
Completed |
Repros Therapeutics Inc. |
2005-01-31 |
| NCT01064960 |
Therapeutic MRI-HIFU Ablation of Uterine Fibroids in a 3T MRI Scanner |
https://ClinicalTrials.gov/show/NCT01064960 |
Completed |
Philips Healthcare |
2011-07-31 |
| NCT01064128 |
Study of Different Pain Scores in Single-Port Access (SPA) Laparoscopic Hysterectomy Versus Conventional Laparoscopic Hysterectomy |
https://ClinicalTrials.gov/show/NCT01064128 |
Completed |
Samsung Medical Center |
2010-12-31 |
| NCT00995878 |
The FIRSTT: Comparing MRgFUS(MR-guided Focused Ultrasound) Versus UAE (Uterine Artery Embolization)for Uterine Fibroids. |
https://ClinicalTrials.gov/show/NCT00995878 |
Completed |
Mayo Clinic |
2016-12-31 |
| NCT00979342 |
Comparative Sedation Study of the MyoSure Hysteroscopic Tissue Removal System |
https://ClinicalTrials.gov/show/NCT00979342 |
Completed |
Hologic, Inc. |
2010-07-31 |
| NCT00971620 |
Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin |
https://ClinicalTrials.gov/show/NCT00971620 |
Completed |
National Institutes of Health Clinical Center (CC) |
2014-01-09 |
| NCT00958334 |
Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003 |
https://ClinicalTrials.gov/show/NCT00958334 |
Completed |
Repros Therapeutics Inc. |
2008-10-15 |
| NCT00897897 |
Therapeutic Magnetic Resonance Imaging (MRI)-Guided High Intensity Focused Ultrasound (HIFU) Ablation of Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT00897897 |
Completed |
Philips Healthcare |
2009-12-31 |
| NCT00891657 |
Post Market Study for an Adhesion Barrier Following Laparoscopic Myomectomy |
https://ClinicalTrials.gov/show/NCT00891657 |
Completed |
Integra LifeSciences Corporation |
2009-05-31 |
| NCT00886873 |
Mifepristone 10 or 5 mg for 6 Months to Treat Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT00886873 |
Completed |
Mediterranea Medica S. L. |
2009-04-30 |
| NCT00882258 |
Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT00882258 |
Completed |
Repros Therapeutics Inc. |
2007-03-31 |
| NCT00881140 |
Efficacy Study of Vaginal Mifepristone to Treat Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT00881140 |
Completed |
BioPro Medical Ltd |
2012-05-31 |
| NCT00874029 |
Laparoscopic Radiofrequency Ablation (RFA) of Symptomatic Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT00874029 |
Completed |
Acessa Health, Inc. |
2012-01-31 |
| NCT00839722 |
Fertility After Uterine Artery Embolisation for the Treatment of Leiomyomas |
https://ClinicalTrials.gov/show/NCT00839722 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2011-07-31 |
| NCT03930069 |
Vasopressin Injection Versus Misoprostol During Hysteroscopic Myomectomy In Reducing Blood Loss And Operation Time. |
https://ClinicalTrials.gov/show/NCT03930069 |
Completed |
Zagazig University |
2017-01-30 |
| NCT00837161 |
Pilot Study of MRI-Guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT00837161 |
Completed |
Philips Healthcare |
2010-02-28 |
| NCT04434066 |
Outcomes on Abdominal Versus Vaginal Morcellation At Time of Hysterectomy |
https://ClinicalTrials.gov/show/NCT04434066 |
Recruiting |
University of Texas Southwestern Medical Center |
2021-06-30 |
| NCT03028610 |
Pregnancy Outcome Following Global Fibroid Ablation Using the Acessaâ„¢ System |
https://ClinicalTrials.gov/show/NCT03028610 |
Recruiting |
University Women’s Hospital Tübingen |
2020-12-31 |
| NCT02925494 |
An Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT02925494 |
Completed |
AbbVie |
2018-05-07 |
| NCT02691494 |
Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (Replicate Study) |
https://ClinicalTrials.gov/show/NCT02691494 |
Completed |
AbbVie |
2018-02-14 |
| NCT03880435 |
HYALOBARRIER® GEL ENDO Versus no HYALOBARRIER® GEL ENDO Following Operative Hysteroscopy for Improving Reproductive Outcome in Women With Intrauterine Pathology Wishing to Become Pregnant |
https://ClinicalTrials.gov/show/NCT03880435 |
Recruiting |
University Hospital, Ghent |
2022-05-01 |
| NCT03796130 |
Does Myomectomy for Intramural Fibroid Improve ART Outcome? |
https://ClinicalTrials.gov/show/NCT03796130 |
Recruiting |
Mansoura University |
2021-04-30 |
| NCT03240523 |
Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT03240523 |
Active, not recruiting |
Bayer |
2021-01-15 |
| NCT02655237 |
A Phase 3 Study to Evaluate the Efficacy and Safety of Relugolix (TAK-385) 40 mg Compared With Leuprorelin in the Treatment of Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT02655237 |
Completed |
Takeda |
2017-05-17 |
| NCT02655224 |
A Placebo-Controlled, Phase 3 Study of Relugolix (TAK-385) 40 mg in the Treatment of Pain Symptoms Associated With Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT02655224 |
Completed |
Takeda |
2017-05-16 |
| NCT02577055 |
Fertility After Myomectomy Versus Uterine Artery Embolization for Symptomatic Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT02577055 |
Active, not recruiting |
Assistance Publique - Hôpitaux de Paris |
2019-11-30 |
| NCT02293447 |
Intra-arterial Lidocaine for Pain Control Post Uterine Fibroid Embolization |
https://ClinicalTrials.gov/show/NCT02293447 |
Completed |
University Health Network, Toronto |
2016-03-31 |
| NCT00776074 |
A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids. |
https://ClinicalTrials.gov/show/NCT00776074 |
Completed |
Takeda |
2007-07-31 |
| NCT00755755 |
PGL4001 Versus Placebo in Uterine Myomas |
https://ClinicalTrials.gov/show/NCT00755755 |
Completed |
PregLem SA |
2010-03-31 |
| NCT00746031 |
Novel MRI Strategies as a Non-invasive Biomarker in Women With Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT00746031 |
Completed |
University of Edinburgh |
2010-09-30 |
| NCT00743080 |
Randomized Controlled Trial (RCT)Comparing GYNAECARE MORCELLEX Versus ROTOCUT GI Tissue Morcellators |
https://ClinicalTrials.gov/show/NCT00743080 |
Completed |
University Magna Graecia |
NA |
| NCT00740831 |
PGL4001 Versus GnRH-agonist in Uterine Myomas |
https://ClinicalTrials.gov/show/NCT00740831 |
Completed |
PregLem SA |
2010-01-31 |
| NCT00731341 |
Hysteroscopic Cryomyolysis for the Treatment of Submucosal Leiomyomata |
https://ClinicalTrials.gov/show/NCT00731341 |
Completed |
Galil Medical, a wholly owned indirect subsidiary of Boston Scientific |
2009-02-28 |
| NCT00712595 |
Mifepristone for Treatment of Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT00712595 |
Completed |
Mediterranea Medica S. L. |
2007-01-31 |
| NCT00628901 |
A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE) |
https://ClinicalTrials.gov/show/NCT00628901 |
Completed |
Boston Scientific Corporation |
2009-12-31 |
| NCT00579475 |
The Effect of Mifepristone on Uterine Fibroids and Breast Tissue |
https://ClinicalTrials.gov/show/NCT00579475 |
Completed |
Karolinska Institutet |
2007-06-30 |
| NCT00543790 |
Study Evaluating PRA-027 Multiple Ascending Doses In Cycling And Postmenopausal Women |
https://ClinicalTrials.gov/show/NCT00543790 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
2008-12-31 |
| NCT00444704 |
Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRA-027 Administered to Healthy Japanese Females |
https://ClinicalTrials.gov/show/NCT00444704 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
NA |
| NCT00365989 |
MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication |
https://ClinicalTrials.gov/show/NCT00365989 |
Completed |
InSightec |
2008-08-31 |
| NCT00361036 |
Comparison Study in the Treatment of Uterine Fibroids Uterine Fibroid Embolization Using BeadBlockâ„¢ Embolic Agent |
https://ClinicalTrials.gov/show/NCT00361036 |
Completed |
Worthington-Kirsch, Robert L., M.D. |
2010-03-31 |
| NCT00332033 |
Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids) |
https://ClinicalTrials.gov/show/NCT00332033 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00295217 |
MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids: Software V4.2 Validation |
https://ClinicalTrials.gov/show/NCT00295217 |
Completed |
InSightec |
NA |
| NCT00290251 |
Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914 |
https://ClinicalTrials.gov/show/NCT00290251 |
Completed |
National Institutes of Health Clinical Center (CC) |
2009-07-31 |
| NCT00152256 |
A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT00152256 |
Completed |
Abbott |
2005-02-28 |
| NCT00166270 |
MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT00166270 |
Completed |
InSightec |
2006-04-30 |
| NCT00160459 |
A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT00160459 |
Completed |
Abbott |
2001-07-31 |
| NCT00160381 |
A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT00160381 |
Completed |
Abbott |
2005-01-31 |
| NCT00159328 |
Efficacy Study of Magnetic Resonance (MR) Guided Focused Ultrasound in the Treatment of Large Fibroids |
https://ClinicalTrials.gov/show/NCT00159328 |
Completed |
Imperial College London |
NA |
| NCT00156208 |
Safety of Treatment of Uterine Fibroids With Asoprisnil |
https://ClinicalTrials.gov/show/NCT00156208 |
Completed |
Abbott |
2006-12-31 |
| NCT00156195 |
Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT00156195 |
Completed |
Abbott |
2007-01-31 |
| NCT00156182 |
A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids. |
https://ClinicalTrials.gov/show/NCT00156182 |
Completed |
Abbott |
2001-12-31 |
| NCT00156156 |
Study of Asoprisnil in the Treatment of Uterine Fibroids. |
https://ClinicalTrials.gov/show/NCT00156156 |
Completed |
Abbott |
2007-02-28 |
| NCT00152269 |
Treatment of Uterine Fibroids With Asoprisnil(J867) |
https://ClinicalTrials.gov/show/NCT00152269 |
Completed |
Abbott |
2005-01-31 |
| NCT00150644 |
A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibroids Who Are Scheduled for a Hysterectomy |
https://ClinicalTrials.gov/show/NCT00150644 |
Completed |
Abbott |
2005-05-31 |
| NCT00131365 |
Magnetic Resonance (MR) Guided Focused Ultrasound Surgery of Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT00131365 |
Completed |
InSightec |
2009-01-31 |
| NCT00100191 |
Emmy Trial: Uterine Artery Embolization (UAE) Versus Hysterectomy for Uterine Fibroids |
https://ClinicalTrials.gov/show/NCT00100191 |
Completed |
ZonMw: The Netherlands Organisation for Health Research and Development |
NA |
| NCT00044876 |
Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective Progesterone Receptor Antagonist |
https://ClinicalTrials.gov/show/NCT00044876 |
Completed |
National Institutes of Health Clinical Center (CC) |
2007-06-16 |